Facilitated By

San Antonio Medical Foundation

Evaluation of Intervir Antiviral Compounds For Inhibition of SARS-Cov2 Replication

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Shtanko, Olena
Collaborating Institutions
Intervir RX
Funded by
Wellcome Trust
Research Start Date
Status
Inactive

Assess 2 compounds for antiviral activity in a cell-based coronavirus infection assay.

Collaborative Project
Drug Discovery
Infectious Disease